Radiotherapy system provided with a program for the calculation of the intensity of an electrons beam
EP2917241A1
Inhibitor of integrin for the treatment or prevention of tumours
EP2624858A1
Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours
WO2011089636A1
Method for in vitro detection of ataxia telangiectasia healthy carriers and related kit
AU2010358867A1
New markers for the epithelial and proliferative or mesenchymal invasive phenotype of human neoplasias
ITRM20090232A1
PEPTIDE IS ABLE TO DISASSEMBLE THE PROTEIN COMPLEXES BETWEEN PROTEIN P53 MUTATA HIS 273 AND P73 ONCOSOPPRESSIVE PROTEIN IN TUMORAL CELLS AND ITS USES IN MEDICAL FIELD.
EP2304051A1
Human mena isoform serve as marker for sensitivity to egfr inhibition in human cancer cells
WO2006111998A1
Recombinant adenoviral vector for the expression of mdm family proteins and uses thereof
WO2006054138A1
PEPTIDE ABLE TO BREAK THE m-p53/p63, m-p53/ p73 AND m-p53/RESPECTIVE ISOFORM PROTEINS COMPLEX FORMED IN THE TUMOR CELLS AND USES THEREOF IN THE PHARMACOLOGICAL FIELD
ITRM940511D0
Process for the in vitro proliferation of cells which have been terminally differentiated through infection with Adenovirus and expression of E1A protein
EP0519876A1
Pharmaceutical preparation to be used as adjuvant treatment of the seborrheic dermatitis even in HIV positive subjects
